申基生物成立于2018年，专注于为客户提供生命科学领域上游原料的整体解决方案。公司多年来致力于生命科学卡脖子原料的研发和产业化，现已具有抗体发现平台、mRNA原液制备平台、mRNA-LNP制剂工艺平台、寡核苷酸制备平台、酶定向进化平台等技术，在此驱动下，衍生细胞基因治疗原料、基因核酸药物原料以及IVD原料三大产品板块。
Founded in 2018, Jiangsu Synthgene Biotechnology Co., Ltd. focuses on providing overall solutions for upstream raw materials in life sciences. Over the years, Synthgene is committed to the development and industrialization of life science insurmountable raw materials. Currently, Synthgene antibody discovery platform, mRNA stock solution preparation platform, mRNA-LNP preparation process platform, oligonucleotide preparation platform, enzyme directed evolution platform contribute to derivative three product segments include cell gene therapy raw materials, gene nucleic acid drug raw materials and IVD raw materials.